Work Area: Trade secrets

Latest content

The digital transformation of IP management still has a long way to go

Saturday Opinion: Though digital IP tools have come a long way, Anushka Arya and Nigel Wong of Rouse Consultancy argue that they have yet to make inroads into the most high-level areas of decision making

12 February 2022

WIPO Proof discontinued after failing to gain traction

The digital timestamping service was officially closed down yesterday. Despite a strong backend, it suffered from competition, miscalibration, and a lack of international legal harmonisation

01 February 2022

How CIPOs identify IP risk and communicate it to top management

At IAM/WTR IP Risk Management event, IP heads from global corporations say speaking the language of the C-suite is critical

31 January 2022

IP concerns now front and centre in supply chain strategies

Saturday Opinion: Retention of IP, trade secrets and talent are increasingly the driving factors in big business decisions about where to conduct R&D and manufacturing

29 January 2022

Biden administration is right to pursue a ‘China Initiative’ reset

Even some of the programme’s architects seem to agree that it has strayed from initial focus on trade secrets and intellectual property

22 January 2022

Japan mulls paying companies to keep sensitive patents under wraps

Economic security law proposed by Japanese government would place restrictions on disclosing patents related to sensitive technologies and innovations

19 January 2022

WHO’s vaccine successes show significance of Moderna covid IP pledge

African tech transfer hub is making fast progress in replicating the approved mRNA jab

18 January 2022

Rise of AI continues to re-write life sciences IP strategies in 2022

A spate of pharma-high tech innovation partnerships have dominated opening days of the year

11 January 2022

AbbVie heads to the ITC in dramatic final battle over Humira biosimilars

Chicago-based company seeking to exclude Alvotech’s adalimumab product from the US market for alleged trade secret misappropriation

10 January 2022

The biggest biopharma patent stories of the year

From President Biden’s backing for a covid IP waiver through a new linkage system in China to big changes in Brazil, it was an action-packed 2021 for the life sciences industries

21 December 2021

Unlock unlimited access to all IAM content